Sun Pharmaceutical Industries Ltd.
Healthcare
US court quashes Ranbaxy's plea against FDA on Nexium, Valcyte generic
A US court has dismissed a plea by Ranbaxy challenging the American drug regulator's move to revoke the 180-day exclusivity ......
Healthcare
Sun Pharma to buy GSK's opiates business in Australia
Sun Pharmaceutical Industries Ltd, the country's most valued pharma company, is buying GlaxoSmithKline's (GSK) opiates business in Australia for an ......
Healthcare
Sun Pharma gets US FTC nod to buy Ranbaxy
The US Federal Trade Commission (FTC) has approved the proposed $4-billion buyout of Ranbaxy Laboratories by Sun Pharmaceutical, the companies ......
Healthcare
Rewind 2014: PE dealmaking in healthcare skids; M&As brighten
Healthcare sector saw private investments shrink in 2014 after hitting an all-time high the previous year. Lack of big ticket ......
Healthcare
CCI clears Sun-Ranbaxy merger deal with riders, asks two companies to divest some products
The long-pending $4-billion merger between Sun Pharma and Ranbaxy today got a conditional approval from fair trade watchdog CCI, which ......
Healthcare
CCI to take final call on Sun Pharma-Ranbaxy deal this month
Competition Commission is likely to finalse this month its decision on the USD 4 billion Sun Pharma-Ranbaxy deal -- the ......
Healthcare
Ranbaxy to pay $40M to settle Texas litigation
Daiichi Sankyo-controlled Indian drug major Ranbaxy Laboratories Ltd, which awaits a regulatory clearance to go ahead with a proposed merger ......
Healthcare
Sun Pharma to raise up to $2B, may use it for M&As
Sun Pharmaceutical Industries Ltd, the country's most valued pharma company, is aiming to raise as much as $2 billion in ......
Healthcare
Sun-Ranbaxy deal: CCI raises concerns about molecules market
The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, today said the major issue is ......
Healthcare
Sun Pharma acquires Pharmalucence
Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has revived its overseas acquisition activity by snapping US-based ......
